GSK plc - Company Profile
Powered by
All the data and insights you need on GSK plc in one report.
$295
- Save hours of research time and resources with
our up-to-date GSK plc Strategy Report
- Understand GSK plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on GSK plc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP2611423B2 | Grant | INHALATIONSMEDIKAMENTE IN TROCKENPULVERFORM MIT FEUCHTIGKEITSREGELUNGSEIGENSCHAFTEN UND VERFAHREN ZU IHRER VERABREICHUNG | A61J3/00; A61K31/137; A61K31/58; A61K9/0075; A61M15/0043; A61M2202/064; A61P11/00; A61P11/06; A61P29/00; A61P43/00; B65B31/00 | September 21, 2022 |
WO2022157155A3 | Application | HSV1 FCE DERIVED FRAGEMENTS FOR THE TREATMENT OF HSV | A61K2039/505; A61K39/12; A61K39/245; C07K14/005; C12N2710/16622; C12N2710/16634 | September 15, 2022 |
WO2022122830A3 | Application | MODIFICATION OF SAPONINS | A61K39/39; C07J63/008; C12N9/2405; C12N9/2445; C12P19/14; C12P19/56; C12P33/00; C12Y302/01021; C12Y302/0104 | September 15, 2022 |
WO2022157153A3 | Application | THERAPEUTIC VIRAL VACCINE | A61K2039/53; A61K2039/58; A61K39/12; A61K39/245; A61P31/22; C12N2710/16034; C12N2710/16071 | September 15, 2022 |
EP3743419B1 | Grant | NEUARTIGE VERBINDUNGEN ZUR BEHANDLUNG PARASITÄRER INFEKTIONEN | A61P33/06; C07D403/12; Y02A50/30 | September 14, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward